A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

Janice Main, Jonathan Brown, C. H. L. Howells, Rachel Galassini, Mary M.E. Crossey, Peter Karayiannis, Panayiotis Georgiou, Gillian Atkinson, Howard C. Thomas

Journal of Viral Hepatitis · 1996 · 127 citations · 18 references

Concepts

Abstract

This is the first double-blind controlled study of famciclovir, an oral antiviral agent, as potential therapy for chronic hepatitis B virus (HBV) carries. A fall of more than 90% in HBV DNA levels was noted in six of 11 evaluable patients treated with a 10 day course of oral famciclovir. Further studies with more prolonged therapy are ongoing.

References

18